So starting first with the patient we are looking at a large cohort of individuals recently diagnosed and we're gonna be following them up over 18 months now over a 10 years period, so this is one of the best studied, best phenotyped, and longest study of its kind in the world. We are also looking at how we can develop better patient models of Parkinson's.